These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32131545)

  • 1. Doxorubicin-Loaded Human Serum Albumin Submicron Particles: Preparation, Characterization and In Vitro Cellular Uptake.
    Chaiwaree S; Prapan A; Suwannasom N; Laporte T; Neumann T; Pruß A; Georgieva R; Bäumler H
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32131545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin Submicron Particles with Entrapped Riboflavin-Fabrication and Characterization.
    Suwannasom N; Smuda K; Kloypan C; Kaewprayoon W; Baisaeng N; Prapan A; Chaiwaree S; Georgieva R; Bäumler H
    Nanomaterials (Basel); 2019 Mar; 9(3):. PubMed ID: 30934597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Cell Capture Using Platelet-Based and Platelet-Mimicking Modified Human Serum Albumin Submicron Particles.
    Zhao X; Georgieva R; Rerkshanandana P; Hackmann M; Heil Olaizola LE; Müller-de Ahna M; Bäumler H
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabrication and Characterization of Human Serum Albumin Particles Loaded with Non-Sericin Extract Obtained from Silk Cocoon as a Carrier System for Hydrophobic Substances.
    Jantakee K; Prapan A; Chaiwaree S; Suwannasom N; Kaewprayoon W; Georgieva R; Tragoolpua Y; Bäumler H
    Polymers (Basel); 2021 Jan; 13(3):. PubMed ID: 33494401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin-loaded albumin submicron particles with potential as a cancer therapy: an in vitro study.
    Suwannasom N; Sriaksorn N; Thepmalee C; Khoothiam K; Prapan A; Bäumler H; Thephinlap C
    Beilstein J Nanotechnol; 2023; 14():1127-1140. PubMed ID: 38034473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oleanolic acid-conjugated human serum albumin nanoparticles encapsulating doxorubicin as synergistic combination chemotherapy in oropharyngeal carcinoma and melanoma.
    Kumbham S; Paul M; Itoo A; Ghosh B; Biswas S
    Int J Pharm; 2022 Feb; 614():121479. PubMed ID: 35041911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium alginate-polyvinyl alcohol-bovin serum albumin coated Fe
    Prabha G; Raj V
    Mater Sci Eng C Mater Biol Appl; 2017 Oct; 79():410-422. PubMed ID: 28629035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity.
    Zhao S; Yu Q; Pan J; Zhou Y; Cao C; Ouyang JM; Liu J
    Acta Biomater; 2017 May; 54():294-306. PubMed ID: 28267598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer.
    Choi SH; Byeon HJ; Choi JS; Thao L; Kim I; Lee ES; Shin BS; Lee KC; Youn YS
    J Control Release; 2015 Jan; 197():199-207. PubMed ID: 25445703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in Vitro Analysis of Human Serum Albumin Nanoparticles Loaded with Anthracycline Derivatives.
    Kimura K; Yamasaki K; Nakamura H; Haratake M; Taguchi K; Otagiri M
    Chem Pharm Bull (Tokyo); 2018; 66(4):382-390. PubMed ID: 29607904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer.
    Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi YW; Choi HG; Park ES; Lee KC; Youn YS
    Pharm Res; 2016 Mar; 33(3):615-26. PubMed ID: 26526555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-triggered drug-release vehicles for synergistic cancer therapy.
    Tu TY; Yang SJ; Tsai MH; Wang CH; Lee SY; Young TH; Shieh MJ
    Colloids Surf B Biointerfaces; 2019 Jan; 173():788-797. PubMed ID: 30384276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and properties of hybrid biopolymer particles fabricated by co-precipitation cross-linking dissolution procedure.
    Xiong Y; Georgieva R; Steffen A; Smuda K; Bäumler H
    J Colloid Interface Sci; 2018 Mar; 514():156-164. PubMed ID: 29248817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Therapeutic Effect of Human Serum Albumin Dimer-Doxorubicin Complex against Human Pancreatic Tumors.
    Kinoshita R; Ishima Y; Chuang VTG; Watanabe H; Shimizu T; Ando H; Okuhira K; Otagiri M; Ishida T; Maruyama T
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-targeted intracellular delivery of anticancer drugs through the mannose-6-phosphate/insulin-like growth factor II receptor.
    Prakash J; Beljaars L; Harapanahalli AK; Zeinstra-Smith M; de Jager-Krikken A; Hessing M; Steen H; Poelstra K
    Int J Cancer; 2010 Apr; 126(8):1966-1981. PubMed ID: 19795464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
    Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
    Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
    Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H
    Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectroscopic and cytotoxicity studies on the combined interaction of (-)-epigallocatechin-3-gallate and anthracycline drugs with human serum albumin.
    Guo Q; Liu M; Zhao Y; Wu Y; Liu J; Cai C; Shi Y; Han J
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Nov; 222():117213. PubMed ID: 31177010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
    Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
    Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoscaled poly(L-glutamic acid)/doxorubicin-amphiphile complex as pH-responsive drug delivery system for effective treatment of nonsmall cell lung cancer.
    Li M; Song W; Tang Z; Lv S; Lin L; Sun H; Li Q; Yang Y; Hong H; Chen X
    ACS Appl Mater Interfaces; 2013 Mar; 5(5):1781-92. PubMed ID: 23410916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.